These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 6428790)

  • 21. Renal and systemic kappa light chain deposits and their plasma cell origin identified by immunoelectron microscopy.
    Silver MM; Hearn SA; Ritchie S; Slinger RP; Sholdice JA; Cordy PS; Hodsman AB
    Am J Pathol; 1986 Jan; 122(1):17-27. PubMed ID: 3079957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphologic manifestations of combined light-chain deposition disease and light-chain cast nephropathy.
    Gokden N; Cetin N; Colakoglu N; Kumar J; Abul-Ezz S; Barlogie B; Liapis H; Walker PD
    Ultrastruct Pathol; 2007; 31(2):141-9. PubMed ID: 17613994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of systemic light-chain deposition disease and amyloidosis: a report of three patients with renal involvement.
    Jacquot C; Saint-Andre JP; Touchard G; Nochy D; D'Auzac de Lamartinie C; Oriol R; Druet P; Bariety J
    Clin Nephrol; 1985 Aug; 24(2):93-8. PubMed ID: 3930115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Light chain nephropathy.
    Tubbs RR; Gephardt GN; McMahon JT; Hall PM; Valenzuela R; Vidt DG
    Am J Med; 1981 Aug; 71(2):263-9. PubMed ID: 6789678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy.
    Ronco P; Plaisier E; Mougenot B; Aucouturier P
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1342-50. PubMed ID: 17699367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated expression of glomerular extracellular matrix proteins and beta 1 integrins in monoclonal light chain-related renal diseases.
    Turbat-Herrera EA; Isaac J; Sanders PW; Truong LD; Herrera GA
    Mod Pathol; 1997 May; 10(5):485-95. PubMed ID: 9160315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Light chain deposition disease without detectable light chains in serum or urine. Report of a case and review of the literature.
    van Ingen G; van Bronswijk H; Meijer CJ; Stel HV
    Neth J Med; 1991 Oct; 39(3-4):142-7. PubMed ID: 1791875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Light chain or monoclonal immunoglobulin deposition disease: physiopathogenic concepts].
    Preud'homme JL; Mihaesco E; Guglielmi P; Morel-Maroger L; Ganeval D; Danon F; Brouet JC; Mihaesco C; Seligmann M
    Nouv Presse Med; 1982 Nov; 11(44):3259-63. PubMed ID: 6818521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
    Picken MM
    Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic approach to and follow-up of difficult cases of AL amyloidosis.
    Perfetti V; Garini P; Vignarelli MC; Marinone MG; Zorzoli I; Merlini G
    Haematologica; 1995; 80(5):409-15. PubMed ID: 8566880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonamyloidotic monoclonal immunoglobulin deposits lack amyloid P component.
    Gallo G; Picken M; Frangione B; Buxbaum J
    Mod Pathol; 1988 Nov; 1(6):453-6. PubMed ID: 3146753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Light-chain glomerulopathy with amyloid-like deposits.
    Alpers CE; Hopper J; Biava CG
    Hum Pathol; 1984 May; 15(5):444-8. PubMed ID: 6427095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association light chain deposition disease (LCDD) and amyloidosis. One case.
    Hofmann-Guilaine C; Nochy D; Jacquot C; Tricottet V; Bariety J; Camilleri JP
    Pathol Res Pract; 1985 Aug; 180(2):214-9. PubMed ID: 3932985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of the usefulness of measuring the serum and urine levels of light chain immunoglobulins in multiple myeloma and Waldenström's macroglobulinemia].
    Kraj M; Maj S; Rostkowska J
    Acta Haematol Pol; 1991; 22(1):21-30. PubMed ID: 1823963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of heavy chain classes and light chain types in 757 cases of monoclonal gammapathies.
    Fine JM; Lambin P
    Biomedicine; 1975 Oct; 23(8):323-7. PubMed ID: 821548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Light-chain deposition disease. Presentation of a case].
    Bertoli G; Ghiringhelli P; Bersiga A; Pecchini F; Betri E
    Pathologica; 1989; 81(1072):203-11. PubMed ID: 2505215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Charge differences between in vivo deposits in immunoglobulin light chain amyloidosis and non-amyloid light chain deposition disease.
    Kaplan B; Livneh A; Gallo G
    Br J Haematol; 2007 Mar; 136(5):723-8. PubMed ID: 17223908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Light chain deposit disease: an anatomopathological entity].
    Hoffman-Guilaine C; Nochy D; Tricottet V; Mallet L; Bariety J; Camilleri JP
    Ann Pathol; 1984; 4(2):105-13. PubMed ID: 6428426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kappa light chain nephropathy. A pathologic study.
    Bangerter AR; Murphy WM
    Virchows Arch A Pathol Anat Histopathol; 1987; 410(6):531-9. PubMed ID: 3105173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunofluorescence characterization of light chains in human nephropathies.
    Orfila C; Rakotoarivony J; Manuel Y; Suc JM
    Virchows Arch A Pathol Anat Histopathol; 1988; 412(6):591-4. PubMed ID: 3129870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.